Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Global Spinal Muscular Atrophy Medicine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025

  • Purchase Options

 
With the slowdown in world economic growth, the Spinal Muscular Atrophy Medicine industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Spinal Muscular Atrophy Medicine market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2018, Stratagem Market Insights analysts believe that in the next few years, Spinal Muscular Atrophy Medicine market size will be further expanded, we expect that by 2023, The market size of the Spinal Muscular Atrophy Medicine will reach XXX million $.
This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.

Section 1: Free——Definition

Section (2 3): 1200 USD——Manufacturer Detail
Astellas Pharma Inc.
AveXis, Inc.
Bioblast Pharma Ltd.
Cytokinetics, Inc. 24
F. Hoffmann-La Roche Ltd.
Genethon
Genzyme Corporation
GMP-Orphan SAS
Ionis Pharmaceuticals, Inc.
Longevity Biotech, Inc
Neurodyn Inc.
Neurotune AG
Novartis AG
Sarepta Therapeutics, Inc.
Voyager Therapeutics, Inc.
Vybion, Inc.
WAVE Life Sciences Ltd.

Section 4: 900 USD——Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)

Section (5 6 7): 500 USD——
Product Type Segmentation
LMI-070
ND-602
NT-1654
Nusinersen
NXD-30001

Industry Segmentation
Hospital
Clinic

Channel (Direct Sales, Distributor) Segmentation

Section 8: 400 USD——Trend (2018-2023)

Section 9: 300 USD——Product Type Detail

Section 10: 700 USD——Downstream Consumer

Section 11: 200 USD——Cost Structure

Section 12: 500 USD——Conclusion

Table of Contents
Section 1 Spinal Muscular Atrophy Medicine Product Definition

Section 2 Global Spinal Muscular Atrophy Medicine Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Spinal Muscular Atrophy Medicine Shipments
2.2 Global Manufacturer Spinal Muscular Atrophy Medicine Business Revenue
2.3 Global Spinal Muscular Atrophy Medicine Market Overview

Section 3 Manufacturer Spinal Muscular Atrophy Medicine Business Introduction
3.1 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Business Introduction
3.1.1 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Shipments, Price, Revenue and Gross profit 2014-2018
3.1.2 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Business Distribution by Region
3.1.3 Astellas Pharma Inc. Interview Record
3.1.4 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Business Profile
3.1.5 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Product Specification

3.2 AveXis, Inc. Spinal Muscular Atrophy Medicine Business Introduction
3.2.1 AveXis, Inc. Spinal Muscular Atrophy Medicine Shipments, Price, Revenue and Gross profit 2014-2018
3.2.2 AveXis, Inc. Spinal Muscular Atrophy Medicine Business Distribution by Region
3.2.3 Interview Record
3.2.4 AveXis, Inc. Spinal Muscular Atrophy Medicine Business Overview
3.2.5 AveXis, Inc. Spinal Muscular Atrophy Medicine Product Specification

3.3 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Business Introduction
3.3.1 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Shipments, Price, Revenue and Gross profit 2014-2018
3.3.2 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Business Distribution by Region
3.3.3 Interview Record
3.3.4 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Business Overview
3.3.5 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Product Specification

3.4 Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Business Introduction
3.5 F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Business Introduction
3.6 Genethon Spinal Muscular Atrophy Medicine Business Introduction
…

Section 4 Global Spinal Muscular Atrophy Medicine Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Spinal Muscular Atrophy Medicine Market Size and Price Analysis 2014-2018
4.1.2 Canada Spinal Muscular Atrophy Medicine Market Size and Price Analysis 2014-2018
4.2 South America Country
4.2.1 South America Spinal Muscular Atrophy Medicine Market Size and Price Analysis 2014-2018
4.3 Asia Country
4.3.1 China Spinal Muscular Atrophy Medicine Market Size and Price Analysis 2014-2018
4.3.2 Japan Spinal Muscular Atrophy Medicine Market Size and Price Analysis 2014-2018
4.3.3 India Spinal Muscular Atrophy Medicine Market Size and Price Analysis 2014-2018
4.3.4 Korea Spinal Muscular Atrophy Medicine Market Size and Price Analysis 2014-2018
4.4 Europe Country
4.4.1 Germany Spinal Muscular Atrophy Medicine Market Size and Price Analysis 2014-2018
4.4.2 UK Spinal Muscular Atrophy Medicine Market Size and Price Analysis 2014-2018
4.4.3 France Spinal Muscular Atrophy Medicine Market Size and Price Analysis 2014-2018
4.4.4 Italy Spinal Muscular Atrophy Medicine Market Size and Price Analysis 2014-2018
4.4.5 Europe Spinal Muscular Atrophy Medicine Market Size and Price Analysis 2014-2018
4.5 Other Country and Region
4.5.1 Middle East Spinal Muscular Atrophy Medicine Market Size and Price Analysis 2014-2018
4.5.2 Africa Spinal Muscular Atrophy Medicine Market Size and Price Analysis 2014-2018
4.5.3 GCC Spinal Muscular Atrophy Medicine Market Size and Price Analysis 2014-2018
4.6 Global Spinal Muscular Atrophy Medicine Market Segmentation (Region Level) Analysis 2014-2018
4.7 Global Spinal Muscular Atrophy Medicine Market Segmentation (Region Level) Analysis

Section 5 Global Spinal Muscular Atrophy Medicine Market Segmentation (Product Type Level)
5.1 Global Spinal Muscular Atrophy Medicine Market Segmentation (Product Type Level) Market Size 2014-2018
5.2 Different Spinal Muscular Atrophy Medicine Product Type Price 2014-2018
5.3 Global Spinal Muscular Atrophy Medicine Market Segmentation (Product Type Level) Analysis

Section 6 Global Spinal Muscular Atrophy Medicine Market Segmentation (Industry Level)
6.1 Global Spinal Muscular Atrophy Medicine Market Segmentation (Industry Level) Market Size 2014-2018
6.2 Different Industry Price 2014-2018
6.3 Global Spinal Muscular Atrophy Medicine Market Segmentation (Industry Level) Analysis

Section 7 Global Spinal Muscular Atrophy Medicine Market Segmentation (Channel Level)
7.1 Global Spinal Muscular Atrophy Medicine Market Segmentation (Channel Level) Sales Volume and Share 2014-2018
7.2 Global Spinal Muscular Atrophy Medicine Market Segmentation (Channel Level) Analysis

Section 8 Spinal Muscular Atrophy Medicine Market Forecast 2018-2023
8.1 Spinal Muscular Atrophy Medicine Segmentation Market Forecast (Region Level)
8.2 Spinal Muscular Atrophy Medicine Segmentation Market Forecast (Product Type Level)
8.3 Spinal Muscular Atrophy Medicine Segmentation Market Forecast (Industry Level)
8.4 Spinal Muscular Atrophy Medicine Segmentation Market Forecast (Channel Level)

Section 9 Spinal Muscular Atrophy Medicine Segmentation Product Type
9.1 LMI-070 Product Introduction
9.2 ND-602 Product Introduction
9.3 NT-1654 Product Introduction
9.4 Nusinersen Product Introduction
9.5 NXD-30001 Product Introduction

Section 10 Spinal Muscular Atrophy Medicine Segmentation Industry
10.1 Hospital Clients
10.2 Clinic Clients

Section 11 Spinal Muscular Atrophy Medicine Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview

Section 12 Conclusion

Chart and Figure
Figure Spinal Muscular Atrophy Medicine Product Picture from Astellas Pharma Inc.
Chart 2014-2018 Global Manufacturer Spinal Muscular Atrophy Medicine Shipments (Units)
Chart 2014-2018 Global Manufacturer Spinal Muscular Atrophy Medicine Shipments Share
Chart 2014-2018 Global Manufacturer Spinal Muscular Atrophy Medicine Business Revenue (Million USD)
Chart 2014-2018 Global Manufacturer Spinal Muscular Atrophy Medicine Business Revenue Share
Chart Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Shipments, Price, Revenue and Gross profit 2014-2018
Chart Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Business Distribution
Chart Astellas Pharma Inc. Interview Record (Partly)
Figure Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Product Picture
Chart Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Business Profile
Table Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Product Specification
Chart AveXis, Inc. Spinal Muscular Atrophy Medicine Shipments, Price, Revenue and Gross profit 2014-2018
Chart AveXis, Inc. Spinal Muscular Atrophy Medicine Business Distribution
Chart AveXis, Inc. Interview Record (Partly)
Figure AveXis, Inc. Spinal Muscular Atrophy Medicine Product Picture
Chart AveXis, Inc. Spinal Muscular Atrophy Medicine Business Overview
Table AveXis, Inc. Spinal Muscular Atrophy Medicine Product Specification
Chart Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Shipments, Price, Revenue and Gross profit 2014-2018
Chart Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Business Distribution
Chart Bioblast Pharma Ltd. Interview Record (Partly)
Figure Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Product Picture
Chart Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Business Overview
Table Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Product Specification
3.4 Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Business Introduction
…
Chart United States Spinal Muscular Atrophy Medicine Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart United States Spinal Muscular Atrophy Medicine Sales Price ($/Unit) 2014-2018
Chart Canada Spinal Muscular Atrophy Medicine Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Canada Spinal Muscular Atrophy Medicine Sales Price ($/Unit) 2014-2018
Chart South America Spinal Muscular Atrophy Medicine Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart South America Spinal Muscular Atrophy Medicine Sales Price ($/Unit) 2014-2018
Chart China Spinal Muscular Atrophy Medicine Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart China Spinal Muscular Atrophy Medicine Sales Price ($/Unit) 2014-2018
Chart Japan Spinal Muscular Atrophy Medicine Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Japan Spinal Muscular Atrophy Medicine Sales Price ($/Unit) 2014-2018
Chart India Spinal Muscular Atrophy Medicine Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart India Spinal Muscular Atrophy Medicine Sales Price ($/Unit) 2014-2018
Chart Korea Spinal Muscular Atrophy Medicine Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Korea Spinal Muscular Atrophy Medicine Sales Price ($/Unit) 2014-2018
Chart Germany Spinal Muscular Atrophy Medicine Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Germany Spinal Muscular Atrophy Medicine Sales Price ($/Unit) 2014-2018
Chart UK Spinal Muscular Atrophy Medicine Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart UK Spinal Muscular Atrophy Medicine Sales Price ($/Unit) 2014-2018
Chart France Spinal Muscular Atrophy Medicine Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart France Spinal Muscular Atrophy Medicine Sales Price ($/Unit) 2014-2018
Chart Italy Spinal Muscular Atrophy Medicine Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Italy Spinal Muscular Atrophy Medicine Sales Price ($/Unit) 2014-2018
Chart Europe Spinal Muscular Atrophy Medicine Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Europe Spinal Muscular Atrophy Medicine Sales Price ($/Unit) 2014-2018
Chart Middle East Spinal Muscular Atrophy Medicine Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Middle East Spinal Muscular Atrophy Medicine Sales Price ($/Unit) 2014-2018
Chart Africa Spinal Muscular Atrophy Medicine Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Africa Spinal Muscular Atrophy Medicine Sales Price ($/Unit) 2014-2018
Chart GCC Spinal Muscular Atrophy Medicine Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart GCC Spinal Muscular Atrophy Medicine Sales Price ($/Unit) 2014-2018
Chart Global Spinal Muscular Atrophy Medicine Market Segmentation (Region Level) Sales Volume 2014-2018
Chart Global Spinal Muscular Atrophy Medicine Market Segmentation (Region Level) Market size 2014-2018
Chart Spinal Muscular Atrophy Medicine Market Segmentation (Product Type Level) Volume (Units) 2014-2018
Chart Spinal Muscular Atrophy Medicine Market Segmentation (Product Type Level) Market Size (Million $) 2014-2018
Chart Different Spinal Muscular Atrophy Medicine Product Type Price ($/Unit) 2014-2018
Chart Spinal Muscular Atrophy Medicine Market Segmentation (Industry Level) Market Size (Volume) 2014-2018
Chart Spinal Muscular Atrophy Medicine Market Segmentation (Industry Level) Market Size (Share) 2014-2018
Chart Spinal Muscular Atrophy Medicine Market Segmentation (Industry Level) Market Size (Value) 2014-2018
Chart Global Spinal Muscular Atrophy Medicine Market Segmentation (Channel Level) Sales Volume (Units) 2014-2018
Chart Global Spinal Muscular Atrophy Medicine Market Segmentation (Channel Level) Share 2014-2018
Chart Spinal Muscular Atrophy Medicine Segmentation Market Forecast (Region Level) 2018-2023
Chart Spinal Muscular Atrophy Medicine Segmentation Market Forecast (Product Type Level) 2018-2023
Chart Spinal Muscular Atrophy Medicine Segmentation Market Forecast (Industry Level) 2018-2023
Chart Spinal Muscular Atrophy Medicine Segmentation Market Forecast (Channel Level) 2018-2023
Chart LMI-070 Product Figure
Chart LMI-070 Product Advantage and Disadvantage Comparison
Chart ND-602 Product Figure
Chart ND-602 Product Advantage and Disadvantage Comparison
Chart NT-1654 Product Figure
Chart NT-1654 Product Advantage and Disadvantage Comparison
Chart Nusinersen Product Figure
Chart Nusinersen Product Advantage and Disadvantage Comparison
Chart NXD-30001 Product Figure
Chart NXD-30001 Product Advantage and Disadvantage Comparison
Chart Hospital Clients
Chart Clinic Clients

 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us